Nevada-based PDL BioPharma, Inc. said it will no longer pursue a proposed acquisition of Neos Therapeutics. Source: BioSpace

The U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Imfinzi to treat patients with unresectable Stage III non-small cell lung cancer (NSCLC). Source: BioSpace

Dynavax announced it has secured a $175 million non-dilutive term loan agreement to commercialize Heplisav-B. Source: BioSpace

Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace

AbbVie today presented new positive results from a Phase 2b dose-ranging study evaluating upadacitinib, an investigational, once-daily oral JAK1-selective inhibitor, in adult patients with moderate to severe atopic dermatitis. Source:…

RELIEF™ trial demonstrated statistically significant reductions in oral ulcers with apremilast 30 mg versus placebo through week 12. Source: BioSpace

AbbVie presented today new positive results from the pivotal Phase 3 ultIMMa-1 and ultIMMa-2 replicate clinical trials that evaluated the safety and efficacy of risankizumab (150 mg) compared to placebo…

The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace

This week MA-based real estate firm Calare Properties acquired the land and buildings for $5M. Source: BioSpace

Detailed results from the JAVELIN Lung 200 trial will be submitted for presentation at an upcoming medical congress. Source: BioSpace